<VariationArchive VariationID="2810534" VariationName="NM_000489.6(ATRX):c.2431del (p.Gln811fs)" VariationType="Deletion" Accession="VCV002810534" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2965208" VariationID="2810534">
      <GeneList>
        <Gene Symbol="ATRX" FullName="ATRX chromatin remodeler" GeneID="546" HGNC_ID="HGNC:886" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="77504880" stop="77786216" display_start="77504880" display_stop="77786216" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="76760355" stop="77041718" display_start="76760355" display_stop="77041718" Strand="-" />
          </Location>
          <OMIM>300032</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATRX">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATRX">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000489.6(ATRX):c.2431del (p.Gln811fs)</Name>
      <CanonicalSPDI>NC_000023.11:77682824:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="77682825" stop="77682825" display_start="77682825" display_stop="77682825" variantLength="1" positionVCF="77682824" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="76938317" stop="76938317" display_start="76938317" display_stop="76938317" variantLength="1" positionVCF="76938316" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Q773fs</ProteinChange>
      <ProteinChange>Q811fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.76938319del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.76938319del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.77682827del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.77682827del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008838.3" sequenceAccession="NG_008838" sequenceVersion="3" change="g.108445del">
            <Expression>NG_008838.3:g.108445del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000489.6" sequenceAccession="NM_000489" sequenceVersion="6" change="c.2431del" MANESelect="true">
            <Expression>NM_000489.6:c.2431del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000480.3" sequenceAccession="NP_000480" sequenceVersion="3" change="p.Gln811fs">
            <Expression>NP_000480.3:p.Gln811fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_138270.5" sequenceAccession="NM_138270" sequenceVersion="5" change="c.2317del">
            <Expression>NM_138270.5:c.2317del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_612114.2" sequenceAccession="NP_612114" sequenceVersion="2" change="p.Gln773fs">
            <Expression>NP_612114.2:p.Gln773fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1153" sequenceAccession="LRG_1153">
            <Expression>LRG_1153:g.108445del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1153t1" sequenceAccession="LRG_1153t1">
            <Expression>LRG_1153t1:c.2429del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1153p1" sequenceAccession="LRG_1153p1" change="p.Gln811Serfs">
            <Expression>LRG_1153p1:p.Gln811Serfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000489.6(ATRX):c.2431del (p.Gln811fs) AND Alpha thalassemia-X-linked intellectual disability syndrome" Accession="RCV003625171" Version="1">
        <ClassifiedConditionList TraitSetID="3190">
          <ClassifiedCondition DB="MedGen" ID="C1845055">Alpha thalassemia-X-linked intellectual disability syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15591283</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18409179</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23681356</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3190" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="281" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alpha-Thalassemia X-Linked Intellectual Disability  Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked alpha-thalassemia-mental retardation syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATR-X syndrome</ElementValue>
                <XRef ID="ATR-X+Syndrome/647" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha thalassemia mental retardation syndrome, nondeletion type, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATR, nondeletion type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">XLMR hypotonic face syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="301040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0018" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Alpha thalassemia-X-linked intellectual disability syndrome</ElementValue>
                <XRef ID="MONDO:0010519" DB="MONDO" />
                <XRef ID="715342005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="301040" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATRX</ElementValue>
                <XRef Type="MIM" ID="301040" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5864" />
                <XRef ID="5864" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay / intellectual disability (DD/ID). Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short triangular nose, tented upper lip, and thick or everted lower lip with coarsening of the facial features over time. While all affected individuals have a normal 46,XY karyotype, genital anomalies comprise a range from hypospadias and undescended testicles, to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Alpha-thalassemia, observed in about 75% of affected individuals, is mild and typically does not require treatment. Osteosarcoma has been reported in a few males with germline pathogenic variants.</Attribute>
                <XRef ID="NBK1449" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301622</ID>
                <ID Source="BookShelf">NBK1449</ID>
              </Citation>
              <XRef ID="847" DB="Orphanet" />
              <XRef ID="C1845055" DB="MedGen" />
              <XRef ID="MONDO:0010519" DB="MONDO" />
              <XRef Type="MIM" ID="301040" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8196206" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="17819222|MedGen:C1845055" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004408927" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15591283</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18409179</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23681356</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ATRX-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln811Serfs*11) in the ATRX gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATRX are known to be pathogenic (PMID: 15591283, 18409179, 23681356).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATRX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.76938317del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845055" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8196206" TraitType="Disease" MappingType="XRef" MappingValue="C1845055" MappingRef="MedGen">
        <MedGen CUI="C1845055" Name="Alpha thalassemia-X-linked intellectual disability syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

